September 2021 – Biosimilar drugs can help save money for both patients and drug plans. Supporting people through a switch from an original drug to a biosimilar one can help them see success with their new treatment. Many provincial drug plans have set up...
The Ontario government is making changes to its OHIP+ Children and Youth Pharmacare program, as you know. The changes affect Ontario residents aged 24 and under, as follows: Those with prescription drug coverage under a private plan will access prescribed...
Check out what our specialists have to say in our recent white paper titled, “Group Benefits Roundtable”. Topics of discussion include Bio-Similars, Managing Diabetes, Adult Vaccinations and dealing with Chronic Pain. Click below for the published article....
Only one-third of Canadian employers feel prepared for the impending legalization of cannabis, according to a new survey produced by Mercer Canada. A total of 366 Canadian employers and more than 1,000 employees, found another third feels somewhat prepared and 27 per...
One of the first things on the Ontario Progressive Conservative agenda was to change OHIP+. Fundamentally the program will be the same, including who is covered and what is covered; however the government will now be 2nd payor instead of 1st payor. Individuals who...
Recent article published by the Benefits & Pension Monitor National pharmacare is no longer an if, but a when, says Chris Bonnett, principal consultant with H3 Consulting. Speaking at The Benefits Alliance Group 2018 AGM and Spring Conference ‘Climbing Higher,’ he...
